Higher abundance of Campylobacter in the oral microbiome of Japanese patients with moyamoya disease

• Published in: Scientific Reports
• Main Authors: Kai Takayanagi, Fumiaki Kanamori, Kazuki Ishii, Kinya Yokoyama, Yoshio Araki, Masaki Sumitomo, Sachi Maeda, Shunsaku Goto, Shinji Ota, Yuichi Nagata, Masahiro Nishihori, Satoshi Maesawa, Takashi Izumi, Syuntaro Takasu, Ryuta Saito
• Format: Article
• Language: English
• Published: Nature Portfolio 2023-10-01
• Online Access: https://doi.org/10.1038/s41598-023-45755-3

Abstract Genetic factors alone cannot explain the pathophysiology of moyamoya disease (MMD), and environmental factors such as an immune response are thought to be involved. Oral and gut microbiomes have attracted attention as environmental factors in the pathophysiology of some vascular and autoimmune diseases. However, the relationship between MMD and these microbiomes is yet to be thoroughly investigated. This prospective case–control study aimed to compare the microbiomes of Japanese patients with MMD with those of healthy individuals to identify the specific bacteria involved in MMD. Saliva and fecal samples were collected from 16 patients with MMD who had not undergone revascularization surgery. Fifteen healthy individuals were matched for age, sex, and body mass index. The microbiomes were determined using 16S rRNA sequencing and analyzed using QIIME2. Differentially abundant microbes were identified using LEfSE and ANCOM-BC. In the oral microbiome, the two analytical methods showed that Campylobacter was more abundant in patients with MMD than in healthy individuals. Differences in the gut microbiome were smaller than those in the oral microbiome. In conclusion, the oral microbiome profiles of patients with MMD significantly differ from those of healthy individuals. Campylobacter spp. could be a substantial environmental factor in the pathophysiology of MMD.